Following a comprehensive national search, Blythedale Children”™s Hospital in Valhalla selected Stephen Leinenweber, M.D., FAAP, as its new chief medical officer (CMO), effective Aug. 1.
Board-certified in pediatrics and pediatric critical care medicine Leinenweber is an experienced clinician, educator and leader who has spent his nearly 30-year career dedicated to the care of children with critical illness and helping lead pediatric health-care organizations.
“”¦He is a highly respected physician and clinical leader with expertise in pediatric critical care medicine. He is an ideal match as we continue to develop innovative ways to care for infants, children and adolescents with increasingly high acuity,” said President and CEO Larry Levine.
Previously Leinenweber”™s was executive medical director of children”™s services and medical director of the Children”™s Hospital at WakeMed Health and Hospitals in Raleigh, North Carolina. Most recently, he served as vice president of strategy for PM Pediatrics.
His clinical experience includes several years as a pediatric critical care (PICU) physician at the children”™s hospitals at Duke University Medical Center, University of North Carolina at Chapel Hill, and WakeMed Health and Hospitals.
“It is the privilege of a lifetime to join Blythedale Children”™s Hospital, an outstanding organization caring for children with complex medical needs and their families for more than a century,” said Leinenweber who received his Bachelor of Arts degree from the University of Notre Dame and graduated from Rush Medical College. He completed his pediatric residency at Cook County Hospital and a fellowship in pediatric critical care at Duke University Children”™s Hospital. He is a fellow of the American Academy of Pediatrics and is licensed in New York, Illinois and North Carolina.
Blythedale is New York state”™s only independent, specialty children”™s hospital and one of only 14 pediatric specialty hospitals in the United States serving patients from birth through age 19.
